Sigilon Therapeutics Ownership 2024 | Who Owns Sigilon Therapeutics Now?
Institutional Ownership
4.20%
Insider Ownership
8.69%
Retail Ownership
87.11%
Institutional Holders
35.00
Sigilon Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -8,872 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -103 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -24,089 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -41,300 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -300,912 | -100.00% | - | Jun 30, 2023 |
| BARCLAYS PLC | - | - | - | -2,343 | -100.00% | - | Jun 30, 2023 |
| FMR LLC | - | - | - | -1,054,600 | -100.00% | - | Jun 30, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -509,629 | -100.00% | - | Jun 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,598 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -246,829 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -96,732 | -100.00% | - | Jun 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,277 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -22,400 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2023 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,600 | -100.00% | - | Jun 30, 2023 |
| HARBOURVEST PARTNERS LLC | - | - | - | -740,740 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -96,499 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -278,520 | -100.00% | - | Jun 30, 2023 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -1,485,185 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,049,169 | -100.00% | - | Jun 30, 2023 |
Sigilon Therapeutics's largest institutional shareholder is BANK OF AMERICA CORP /DE/, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -8,872 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -103 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -24,089 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -41,300 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -300,912 | -100.00% | - | Jun 30, 2023 |
| BARCLAYS PLC | - | - | - | -2,343 | -100.00% | - | Jun 30, 2023 |
| FMR LLC | - | - | - | -1,054,600 | -100.00% | - | Jun 30, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -509,629 | -100.00% | - | Jun 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,598 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -246,829 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -96,732 | -100.00% | - | Jun 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,277 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -22,400 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2023 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,600 | -100.00% | - | Jun 30, 2023 |
| HARBOURVEST PARTNERS LLC | - | - | - | -740,740 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -96,499 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -278,520 | -100.00% | - | Jun 30, 2023 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -1,485,185 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,049,169 | -100.00% | - | Jun 30, 2023 |
The largest Sigilon Therapeutics shareholder by % of total assets is BANK OF AMERICA CORP /DE/. The company owns 0.00 shares of Sigilon Therapeutics (SGTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -103 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -708 | -100.00% | - | Jun 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,277 | -100.00% | - | Jun 30, 2023 |
| BARCLAYS PLC | - | - | - | -2,343 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -8,872 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -10,400 | -100.00% | - | Jun 30, 2023 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,600 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,417 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -22,400 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -24,089 | -100.00% | - | Jun 30, 2023 |
| SOUNDMARK WEALTH MANAGEMENT, LLC | - | - | - | -25,555 | -100.00% | - | Jun 30, 2023 |
| GROUND SWELL CAPITAL, LLC | - | - | - | -25,640 | -100.00% | - | Jun 30, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -27,596 | -100.00% | - | Jun 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,598 | -100.00% | - | Jun 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -31,542 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -41,300 | -100.00% | - | Jun 30, 2023 |
| CHOATE INVESTMENT ADVISORS | - | - | - | -66,666 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -96,499 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Sigilon Therapeutics's largest institutional buyer is NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC. The company purchased -40.00 stocks of SGTX, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | - | - | - | -10,370,369 | -100.00% | - | Jun 30, 2023 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -1,485,185 | -100.00% | - | Jun 30, 2023 |
| FMR LLC | - | - | - | -1,054,600 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,049,169 | -100.00% | - | Jun 30, 2023 |
| CERCANO MANAGEMENT LLC | - | - | - | -884,920 | -100.00% | - | Jun 30, 2023 |
| HARBOURVEST PARTNERS LLC | - | - | - | -740,740 | -100.00% | - | Jun 30, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -509,629 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -300,912 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -278,520 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -246,829 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -96,732 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -96,499 | -100.00% | - | Jun 30, 2023 |
| CHOATE INVESTMENT ADVISORS | - | - | - | -66,666 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -41,300 | -100.00% | - | Jun 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -31,542 | -100.00% | - | Jun 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,598 | -100.00% | - | Jun 30, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -27,596 | -100.00% | - | Jun 30, 2023 |
| GROUND SWELL CAPITAL, LLC | - | - | - | -25,640 | -100.00% | - | Jun 30, 2023 |
| SOUNDMARK WEALTH MANAGEMENT, LLC | - | - | - | -25,555 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Sigilon Therapeutics's biggest institutional seller is FLAGSHIP PIONEERING INC.. The company sold -10.37M shares of SGTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | - | - | - | -10,370,369 | -100.00% | - | Jun 30, 2023 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -1,485,185 | -100.00% | - | Jun 30, 2023 |
| FMR LLC | - | - | - | -1,054,600 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,049,169 | -100.00% | - | Jun 30, 2023 |
| CERCANO MANAGEMENT LLC | - | - | - | -884,920 | -100.00% | - | Jun 30, 2023 |
| HARBOURVEST PARTNERS LLC | - | - | - | -740,740 | -100.00% | - | Jun 30, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -509,629 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -300,912 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -278,520 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -246,829 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -96,732 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -96,499 | -100.00% | - | Jun 30, 2023 |
| CHOATE INVESTMENT ADVISORS | - | - | - | -66,666 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -41,300 | -100.00% | - | Jun 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -31,542 | -100.00% | - | Jun 30, 2023 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,598 | -100.00% | - | Jun 30, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -27,596 | -100.00% | - | Jun 30, 2023 |
| GROUND SWELL CAPITAL, LLC | - | - | - | -25,640 | -100.00% | - | Jun 30, 2023 |
| SOUNDMARK WEALTH MANAGEMENT, LLC | - | - | - | -25,555 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -24,089 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -22,400 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,417 | -100.00% | - | Jun 30, 2023 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,600 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -10,400 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -8,872 | -100.00% | - | Jun 30, 2023 |
| BARCLAYS PLC | - | - | - | -2,343 | -100.00% | - | Jun 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,277 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -708 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -103 | -100.00% | - | Jun 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -100 | -100.00% | - | Jun 30, 2023 |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2023 |
Sigilon Therapeutics's largest sold out institutional shareholder by shares sold is FLAGSHIP PIONEERING INC., sold -10.37M shares, valued at -, as of undefined.
Sigilon Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.21% | 564,538 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.08% | 19,555 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 125,000 | - | - | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 540,170 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 26,860 | - | - | Feb 29, 2024 |
| Gabelli 787 Fund, Inc. | 0.01% | 500 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 9,615 | - | - | Mar 28, 2024 |
| UBS FUNDS | 0.00% | 17,555 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,035 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.00% | 8,550 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 111,933 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 10,362 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 40,465 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 40,900 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.00% | 297 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 722 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 31,572 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 276,917 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,777 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,730 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 7,307 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 92,379 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 7,550 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 628 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 7,300 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 4,476 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 3,010 | - | - | Mar 31, 2024 |
| GDL FUND | 0.00% | 100 | - | - | Dec 29, 2023 |
| JPMorgan Trust I | 0.00% | 86,100 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 5,800 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,700 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,033 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 21,300 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 332,626 | - | - | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 27,659 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 1,363 | - | - | Mar 31, 2024 |
| GABELLI INVESTOR FUNDS INC | 0.00% | 100 | - | - | Dec 29, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 146 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 7,047 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 122,381 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 325 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,256 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 49,313 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 536 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 80 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 5,634 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,051 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 90 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 40,939 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 14 | - | - | Dec 31, 2023 |
| ALLSPRING FUNDS TRUST | 0.00% | 4,881 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,317 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 10,125 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 8,206 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,100 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,184 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 2,030 | - | - | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 50,651 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 761 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 11,640 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,677 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 96 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 12,499 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 25,586 | - | - | Mar 28, 2024 |
| Brighthouse Funds Trust I | 0.00% | 24,625 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 312 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 11,029 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 42,217 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,867 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,190 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 4,902 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 6 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 622 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,423 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 863 | - | - | Mar 31, 2024 |
Sigilon Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 564.54K shares, compromising 0.21% of its total assets.
Sigilon Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 35 | 16.67% |
| 31 Dec, 22 | 30 | 3.45% |
| 30 Sep, 22 | 29 | -9.38% |
| 30 Jun, 22 | 32 | -31.91% |
| 31 Mar, 22 | 47 | -6.00% |
| 31 Dec, 21 | 50 | 6.38% |
| 30 Sep, 21 | 47 | -9.62% |
| 30 Jun, 21 | 52 | 1.96% |
| 31 Mar, 21 | 51 | 13.33% |
| 31 Dec, 20 | 45 | - |
As of 31 Mar 23, 35 institutions are holding Sigilon Therapeutics's shares, representing an increase of 16.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 17,713,350 | 1.23% |
| 31 Dec, 22 | 17,498,685 | 3.31% |
| 30 Sep, 22 | 16,937,301 | -0.82% |
| 30 Jun, 22 | 17,076,790 | -6.35% |
| 31 Mar, 22 | 18,233,840 | -3.61% |
| 31 Dec, 21 | 18,917,605 | -1.94% |
| 30 Sep, 21 | 19,291,632 | -1.05% |
| 30 Jun, 21 | 19,496,408 | -0.64% |
| 31 Mar, 21 | 19,621,954 | -0.07% |
| 31 Dec, 20 | 19,635,552 | - |
Sigilon Therapeutics (SGTX) has 17.71M shares outstanding as of 31 Mar 23, up 1.23% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 4.20% | 24.41% |
| 31 Dec, 22 | 4.15% | 25.64% |
| 30 Sep, 22 | 4.02% | 24.46% |
| 30 Jun, 22 | 4.05% | 21.58% |
| 31 Mar, 22 | 4.33% | 21.37% |
| 31 Dec, 21 | 4.50% | 21.01% |
| 30 Sep, 21 | 4.63% | 20.52% |
| 30 Jun, 21 | 4.75% | 20.67% |
| 31 Mar, 21 | 4.79% | 20.83% |
| 31 Dec, 20 | 4.80% | - |
As of 31 Mar 23, Sigilon Therapeutics is held by 4.20% institutional shareholders, representing a 24.41% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 12 | 9.09% |
| 31 Dec, 22 | 11 | 57.14% |
| 30 Sep, 22 | 7 | -12.50% |
| 30 Jun, 22 | 8 | -38.46% |
| 31 Mar, 22 | 13 | -53.57% |
| 31 Dec, 21 | 28 | -3.45% |
| 30 Sep, 21 | 29 | 7.41% |
| 30 Jun, 21 | 27 | -6.90% |
| 31 Mar, 21 | 29 | -35.56% |
| 31 Dec, 20 | 45 | - |
12 institutional shareholders have increased their position in SGTX stock as of 31 Mar 23 compared to 11 in the previous quarter (a 9.09% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 8 | - |
| 31 Dec, 22 | 8 | -33.33% |
| 30 Sep, 22 | 12 | -14.29% |
| 30 Jun, 22 | 14 | -33.33% |
| 31 Mar, 22 | 21 | 90.91% |
| 31 Dec, 21 | 11 | 37.50% |
| 30 Sep, 21 | 8 | -50.00% |
| 30 Jun, 21 | 16 | 45.45% |
| 31 Mar, 21 | 11 | - |
| 31 Dec, 20 | - | - |
8 institutional shareholders have reduced their position in SGTX stock as of 31 Mar 23 compared to 8 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 35 | 16.67% | 17,713,350 | 1.23% | 4.20% | 24.41% | 12 | 9.09% | 8 | - |
| 31 Dec, 22 | 30 | 3.45% | 17,498,685 | 3.31% | 4.15% | 25.64% | 11 | 57.14% | 8 | -33.33% |
| 30 Sep, 22 | 29 | -9.38% | 16,937,301 | -0.82% | 4.02% | 24.46% | 7 | -12.50% | 12 | -14.29% |
| 30 Jun, 22 | 32 | -31.91% | 17,076,790 | -6.35% | 4.05% | 21.58% | 8 | -38.46% | 14 | -33.33% |
| 31 Mar, 22 | 47 | -6.00% | 18,233,840 | -3.61% | 4.33% | 21.37% | 13 | -53.57% | 21 | 90.91% |
| 31 Dec, 21 | 50 | 6.38% | 18,917,605 | -1.94% | 4.50% | 21.01% | 28 | -3.45% | 11 | 37.50% |
| 30 Sep, 21 | 47 | -9.62% | 19,291,632 | -1.05% | 4.63% | 20.52% | 29 | 7.41% | 8 | -50.00% |
| 30 Jun, 21 | 52 | 1.96% | 19,496,408 | -0.64% | 4.75% | 20.67% | 27 | -6.90% | 16 | 45.45% |
| 31 Mar, 21 | 51 | 13.33% | 19,621,954 | -0.07% | 4.79% | 20.83% | 29 | -35.56% | 11 | - |
| 31 Dec, 20 | 45 | - | 19,635,552 | - | 4.80% | - | 45 | - | - | - |
Sigilon Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Sigilon Therapeutics's stock was made by Flagship Ventures Fund V General Partner LLC on Aug 15 2023, selling 113,960 shares at $14.92 per share (valued at $1.70M). The last insider buy of SGTX was made by ELI LILLY & Co on Aug 14 2023, buying 1,718,493 shares at $14.92 per share (worth $25.64M).
Sigilon Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 3 | 27 | 11.11% |
| Q2 2023 | 6 | 1 | 600.00% |
| Q1 2023 | 5 | 6 | 83.33% |
| Q2 2022 | 8 | - | - |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 3 | 2 | 150.00% |
| Q2 2021 | 7 | 5 | 140.00% |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 10 | 28 | 35.71% |
3 total buy trades, and 27 total sell trades (buy/sell ratio of 0.11%) were made by Sigilon Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 2 | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sigilon Therapeutics's stocks.
Sigilon Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| GOVX | GeoVax Labs, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| ONCR | Oncorus, Inc. |
| INM | InMed Pharmaceuticals Inc. |
| APLM | Apollomics, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| PHIO | Phio Pharmaceuticals Corp. |
| LABP | Landos Biopharma, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| UNCY | Unicycive Therapeutics, Inc. |
| CDIO | Cardio Diagnostics Holdings, Inc. |
SGTX Ownership FAQ
Who Owns Sigilon Therapeutics?
Sigilon Therapeutics is owned by institutional shareholders (4.20%), insiders (8.69%), and public (87.11%). The largest institutional shareholder of Sigilon Therapeutics is BANK OF AMERICA CORP /DE/ (0% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.21% of total shares).
Who are the major institutional shareholders of Sigilon Therapeutics?
Sigilon Therapeutics's major institutional shareholders are BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, and VANGUARD GROUP INC. The top five shareholders own together 0% of the company's share outstanding.
How many Sigilon Therapeutics shareholders are there?
As of Mar 2023, there are 35 institutional shareholders of Sigilon Therapeutics.
What percentage of Sigilon Therapeutics is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ owns 0 shares of Sigilon Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).
What percentage of Sigilon Therapeutics is owned by WELLS FARGO & COMPANY/MN?
As of Jun 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Sigilon Therapeutics (SGTX), compromising 0% of the company, valued at $0.
What percentage of Sigilon Therapeutics is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Sigilon Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).